Kidswell Bio Corporation
キッズウェル・バイオ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4584
FY2025 · 2026-03-31
| Gross margin | 26.5% |
| Operating margin | -2.1% |
| Net margin | -6.3% |
| Return on equity | -27.3% |
| Return on assets | -6.8% |
| Revenue growth (YoY) | 29.7% |
| EPS (basic) | ¥-8.48 |
| EPS growth (YoY) | — |
| Current ratio | 2.72x |
| Equity ratio | 24.9% |
| Book value / share | ¥32.37 |
| Free cash flow | -1,114 M |